Patrick J. McEnany - 13 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
13 Aug 2021
Net transactions value
-$72,065
Form type
4
Filing time
17 Aug 2021, 16:53:55 UTC
Next filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $312,000 +100,000 +2.1% $3.12* 4,911,019 13 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $192,542 -31,186 -0.64% $6.17 4,879,833 13 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $191,523 -31,529 -0.65% $6.07 4,848,304 13 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -100,000 -2.8% $0.000000 3,451,667 13 Aug 2021 Common Stock 100,000 $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Options vested in three annual tranches beginning on August 28, 2015.